Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease)

Area of Science:

• Cardiology
• Infectious Diseases
• Parasitology

Background:

• Chagas disease, caused by the parasite Trypanosoma cruzi, is a significant cause of heart disease in endemic Latin American regions.
• Chagasic cardiomyopathy affects 10-30% of chronically infected individuals, presenting a major public health challenge.
• The 100th anniversary of its discovery highlights the long-standing impact of this parasitic infection.

Discussion:

• Echocardiography and MRI are crucial for evaluating and predicting outcomes in patients with Chagasic heart disease.
• The multifactorial etiology of Chagasic heart disease involves parasite persistence, autoimmunity, and microvascular issues.
• Alterations in cardiac gap junctions are implicated in the pathogenesis of conduction abnormalities.

Key Insights:

• Diagnosis of chronic Chagas disease relies on serological testing.
• Current treatment options for Chagas disease are limited and require improvement.
• Cardiac transplantation and bone marrow stem cell therapy are emerging as promising research avenues.

Outlook:

• Further research is needed to address treatment shortcomings for Chagas disease.
• Investigating novel therapeutic strategies, including stem cell therapy, is critical for managing Chagasic cardiomyopathy.
• Continued exploration of pathogenic mechanisms will refine prognostication and treatment approaches.